Chartanalyse Cooper Companies: Qualitätsaktie im Aufwind
Die Aktie bietet mittelfristig fast 30 % Potenzial.
Was macht Cooper Companies?
Unternehmensprofil
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Chart der Cooper Companies Aktie
Charttool öffnen
Aktuelle Nachrichten zu Cooper Companies
Weitere Nachrichten
Unsere neuesten Artikel zu Cooper Companies
Das berichten andere über Cooper Companies
3 Reasons Why Growth Investors Shouldnt Overlook The Cooper Companies (COO)
The Cooper Companies (COO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Cooper Companies (COO) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
The Cooper Companies (COO) Loses 8.8% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
The Cooper Companies (COO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street...
COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook
Cooper Companies tops Q1 EPS estimates and lifts FY26 outlook as MyDay and MiSight drive growth. Shares slip despite solid margin expansion.
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.